MYCOPLASM M (Mycophenolate Mofetil 500 mg)

Introduction

MYCOPLASM M 500 is a potent immunosuppressive medication containing Mycophenolate Mofetil 500mg, designed to help patients undergoing organ transplantation or dealing with autoimmune diseases. This medicine plays a critical role in preventing organ rejection after kidney, heart, or liver transplants and is also prescribed in certain cases of autoimmune disorders such as lupus nephritis or rheumatoid arthritis.

Key Features and Ingredients

• Brand Name: MYCOPLASM M 500

• Active Ingredient: Mycophenolate Mofetil 500mg

• Drug Class: Immunosuppressant

• Dosage Form: Oral Tablet

• Packaging: Blister pack for safety and convenience

• Manufactured under: WHO GMP certified facility

Usage and Dosage

Indicated for

• Prevention of organ rejection in renal, hepatic, and cardiac transplants

• Immunosuppressive therapy in autoimmune diseases like

  • Systemic Lupus Erythematosus SLE

  • Myasthenia Gravis

  • Psoriasis

  • Pemphigus Vulgaris

Typical Dosage

• Adults 500mg to 1000mg twice daily based on clinical need

• Always follow your doctor’s exact prescription

Benefits of MYCOPLASM M 500

• Prevents immune-mediated organ rejection

• Reduces dependency on high-dose corticosteroids

• Provides targeted immune suppression with fewer cosmetic side effects

• Improves transplant success rate

• Oral tablet form ensures easy administration

Mechanism of Action

Mycophenolate Mofetil is metabolized into Mycophenolic Acid MPA, which inhibits the enzyme inosine monophosphate dehydrogenase IMPDH. This enzyme is essential for the proliferation of T and B lymphocytes, the primary cells involved in organ rejection. By blocking this pathway, MYCOPLASM M 500 effectively reduces immune activity and promotes graft survival.

Precautions and Warnings

• Contraindicated in pregnancy as it can cause birth defects or miscarriage

• Not recommended during breastfeeding

• Patients should use effective contraception during and for 6 weeks after therapy

• Monitor regularly for

  • Infections

  • Blood counts

  • Liver function

  • Gastrointestinal disturbances

Possible Side Effects

Common

• Nausea and vomiting

• Diarrhea

• Fatigue

• Headache

Serious

• Opportunistic infections

• Leukopenia low white blood cells

• Anemia

• Liver toxicity

Immediate medical attention is required in case of high fever, persistent diarrhea, unusual bleeding, or signs of infection.

Storage Instructions

• Store at a temperature below 25 degrees Celsius

• Keep tablets in the original packaging

• Protect from light and moisture

• Keep out of reach of children

Frequently Asked Questions

1. What is MYCOPLASM M 500 used for?
MYCOPLASM M 500 is used to prevent rejection of transplanted organs such as the kidney, liver, or heart. It is also prescribed in certain autoimmune diseases like lupus nephritis, rheumatoid arthritis, and myasthenia gravis under medical supervision.

2. Can I take MYCOPLASM M 500 during pregnancy?
No, MYCOPLASM M 500 is strictly contraindicated during pregnancy due to the high risk of birth defects and miscarriage. Effective contraception is mandatory during treatment and for at least 6 weeks after stopping the medication.

3. Is it safe to use with other medications?
Caution is required. MYCOPLASM M 500 can interact with various medications such as antacids, antivirals, antibiotics, and other immunosuppressants. Always inform your doctor about all the medicines and supplements you are taking.

4. How long do I need to take this medicine after a transplant?
The duration of treatment varies from patient to patient. In most cases, long-term or lifelong use is necessary to prevent organ rejection. Your doctor will monitor and adjust the treatment as needed.

5. Is monitoring required during treatment?
Yes. Regular monitoring is crucial while taking MYCOPLASM M 500. This includes blood tests, liver and kidney function tests, and checks for infection or abnormal bleeding to ensure safe and effective use of the medication.

Conclusion

MYCOPLASM M 500 Mycophenolate Mofetil 500mg is an essential therapy in organ transplant care and autoimmune disease management, offering proven results with a high safety profile when used under medical supervision. It plays a key role in improving patient outcomes and ensuring long-term organ viability.

About The Author

STERIS HEALTHCARE PVT LTD

Steris Healthcare Pvt Ltd, known as Sterispharma, was founded in February 2018 by a team of experienced professionals in the pharmaceutical industry. Headquartered in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, reflecting its dedication to maintaining high standards of quality and safety. Sterispharma’s mission is to provide affordable, high-quality medications across India, strictly adhering to WHO guidelines. With the convenience of an online pharmacy, customers can easily order medicines with home delivery options.

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp: 8209542042 , 8824175417

BUY NOW